Canopy Growth (TSX:WEED) Stock: $0 or $100?

Industries across the board continue to suffer thanks to the COVID-19 pandemic. It seems no industry immune to the financial devastation it can cause, including the cannabis industry. Despite the increase in demand and sales of cannabis while people stay home, that hasn’t fixed the problem cannabis suppliers like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) continue to have: a means of supplying that…

Read More

What Aphria’s Move From the NYSE to the NASDAQ Means for Stock Investors

In an unexpected move on Tuesday, one of Canada’s largest marijuana firms Aphria (TSX:APHA)(NYSE:APHA) announced that it is moving its U.S. stock listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market effective on Monday, June 8. Aphria’s stock listing migration will take place soon after the firm closes its fiscal year 2020 financial books on…

Read More

Cannabis Investors: A Boom Is Coming

It’s official. The cannabis bubble has definitely burst. Across the board even the biggest cannabis stocks have come crashing down. Even before the pandemic, these stocks were in trouble. Now that COVID-19 is still sweeping the world, these cannabis stocks have an incredibly long road ahead. However, there are a few signs of life out there that investors should look…

Read More

Canopy Growth (TSX:WEED) Stock: Is the End Near?

If there’s one industry that has been incredibly frustrating for investors of late, it’s the cannabis industry. Canopy Growth (TSX:WEED)(NYSE:CGC) in particular used to be the darling of the industry, but that has all changed. WEED stock plummeted from all-time highs back in October 2018 after legalization. Since then, WEED stock has struggled to get anywhere near those highs again. Then, the…

Read More

Top TSX Stocks to Buy After the Market Crash

The market crash has been difficult, but it’s unearthed some incredible bargains. You need a bit of courage, and a lot of patience, but this looks like your best chance to buy high-upside stocks in nearly a decade. While many stocks will rebound once markets normalize, the biggest opportunities lie with companies targeting multi-decade opportunities. Whether its artificial intelligence, legal…

Read More

Will Cronos (TSX:CRON) Stock Fall Below $5?

Cronos Group (TSX:CRON)(NASDAQ:CRON) was once the hottest pot company in the world. From late 2014 to early 2019, Cronos stock rose in value by nearly 4,000%. The marijuana bear market of 2019 changed everything. Last year, virtually every pot stock lost more than 50% of its value. Cronos went from a $12 billion company to a valuation of less than…

Read More

Canopy Growth Stock Lagged the TSX by 5.7% in March

Canopy Growth (TSX:WEED)(NYSE:CGC) stock price was already in the throes of despair before the coronavirus crisis. The stock had already fallen dramatically from late 2018/early 2019 highs as the cannabis bubble burst. In March, Canopy Growth stock price continued to underperform the TSX, lagging it by 5.7%. During the month of March, all eyes were on developments related to the…

Read More

Aurora Cannabis (TSX:ACB) and HEXO (TSX:HEXO) Will Love This NYSE Rules Waiver

News on Monday was that the New York Stock Exchange, one of the largest exchanges in the world, is in talks with the U.S. Securities and Exchange Commission (SEC) in an effort to temporarily ease continued listing requirements for companies whose equities are traded on its platform. Marijuana producers Aurora Cannabis (TSX:ACB)(NYSE:ACB) and HEXO (TSX:HEXO)(NYSE:HEXO) are some of the many…

Read More

Cronos Group Stock Price to Suffer an Earnings Restatement Penalty

Cronos Group (TSX:CRON)(NASDAQ:CRON) stock price fell by 12% early on Wednesday to give up some of its near 13% gains on Tuesday after the marijuana firm said it will effect a 40% charge on its third quarter 2019 revenue and will make a similar adjustment in its restated Q1 2019 earnings results. Cronos will reduce its first-quarter and third-quarter revenues…

Read More

3 Takeaways From Aurora Cannabis’s (TSX:ACB) Founder’s Massive Stock Sale

Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) founder, director, and former CEO Terry Booth has made a massive sale of 12,161,900 shares on his Aurora Cannabis stock position on the open market over the past few days. Should investors read much into this corporate insider’s latest move? Mr. Booth made four separate large sell transactions of millions of Aurora shares at stock prices ranging…

Read More